Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference

The European Society of Cardiology Congress that kicks off Friday in Munich will be a consequential meeting for Alnylam Pharmaceuticals.

STAT+: Alnylam’s heart drug troubles take center stage at a cardiology conference

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Also reported by 2 other outlets

Read the original at statnews.com →

More in Health & Medicine

More from Thursday 27 August →